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This entertaining, well-written book pro-
vides valuable insights into three inter-
related areas, all built around the story of
the Cutter incident, a landmark case that
in some ways continues to have implica-
tions for product liability and the health
of the vaccine industry today. The
author, Paul Offit, has an admirable ability
to present complicated issues in a way that is easy to
understand for both technical and nontechnical audiences,
and the book should (and does) have wide appeal.
The first part of the story deals with the actual incident, which
involved the failure to completely inactivate the very first lots of inacti-
vated poliovaccine licensed for use in the United States, and the result-
ing epidemic of iatrogenic paralytic polio. This incident holds many
lessons for us today. Offit shows how the ultimate outbreak was really
the consequence of multiple factors: an inactivation procedure that
was not completely understood by the manufacturers, testing algo-
rhythms that were relatively insensitive for detection of remaining live
virus in the final preparations, the use of an extremely virulent virus as
the starting material for one of the three strains, and, most unpre-
dictable of all, the enormous consequences of a seemingly trivial
process change—the substitution of glass filters in a critical step in the
processing of the culture lysates. Most disasters are the result of multi-
ple synergistic failures, not all of which are predictable, and the Cutter
incident is a good illustration of this.
The second part of the story describes the resulting product
liability trial, in which the manufacturer of the vaccine, Cutter
Laboratories, was found to be liable even though it was not negligent.
Cutter followed all available guidelines in production of the vaccine
and only released lots that had passed recommended safety tests.
However, the vaccine, rather than preventing polio as it was supposed
to do, actually caused polio instead. In the trial, the jury did not find
Cutter to have been negligent in the manufacture of the vaccine.
However, Cutter was found to have violated the implied warranty that
its product, when used as directed, would be safe and effective for its
intended purpose. The author makes a convincing argument that this
case set a precedent for liability without negligence that ultimately
almost destroyed the vaccine industry in the United States. Only the
Vaccine Injury Compensation Program, in which claims against
manufacturers are first arbitrated by a panel of experts, has kept manu-
facturers in the game.
The third part of the story is a more speculative discussion of the
role product liability has played in the currently tenuous situation fac-
ing our supply of critical vaccines in the United States. This complex
situation involves not only product liability but the economics of the
marketplace, the role of government funding for vaccines, and proba-
bly other issues as well. However, product liability clearly also plays a
role, and continues to have an impact today. For example, legislation
protecting manufacturers of potential pandemic vaccines against prod-
uct liability claims has emerged as a critical issue, which will be
required for adequate control of the current avian influenza threat,
much as it was in 1976. Thimerosal, which has now been convincingly
demonstrated to have no association with neurodevelopmental disor-
ders, has in the meantime continued to be a source of liability claims
and state legislation.
Vaccines have had a profound influence on human health and
have been responsible for the complete elimination of smallpox, the
elimination of measles and polio transmission in the Western
Hemisphere, and many other benefits. However, to be effective, vac-
cines must be administered to very large numbers of healthy individu-
als. For this reason, vaccine safety always has been, and will remain, a
preeminent concern among those involved in controlling human dis-
ease. This book should be of value to anyone who must deal with issues
related to exposure of large populations to interventions.
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